Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In 2024, Wegovy received an additional FDA indication to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight
YJ: Formal Analysis, Funding acquisition, Supervision, Visualization, Writing review and editing
Mild side effects, if present, may include nausea or bloating, especially during the first few weeks of dose adjustment
The table below outlines typical cost structures and projected trends based on market analysis and competitive landscape
Pregnancy and Breastfeeding This medicine is not suitable for use in pregnancy and breastfeeding
It's best to check the choline content [36] of food and the portion size for a better understanding of how much choline is being consumed
US$ 29.09
US$ 25.25
US$ 22.48
